# CEBPE

## Overview
The CEBPE gene encodes the CCAAT/enhancer-binding protein epsilon (C/EBPε), a transcription factor belonging to the basic leucine zipper (bZIP) family. This protein plays a pivotal role in the differentiation and function of granulocytes, particularly neutrophils and eosinophils, by regulating the transcription of genes essential for the formation and function of neutrophil granules (Serwas2018CEBPE-Mutant). C/EBPε is characterized by its bZIP domain, which facilitates DNA binding and dimerization, crucial for its function as a transcription factor (Serwas2018CEBPE-Mutant). The gene's expression is tightly regulated during granulocyte development, peaking at the myelocyte and metamyelocyte stages, and is almost absent in mature cells, indicating its role in early differentiation (Serwas2018CEBPE-Mutant). Mutations in CEBPE are linked to hematological disorders such as specific granule deficiency and certain autoinflammatory conditions, highlighting its clinical significance (Serwas2018CEBPE-Mutant; Göös2019Gainoffunction).

## Structure
The CEBPE gene encodes the transcription factor CCAAT/enhancer-binding protein epsilon (C/EBPε), which is involved in granulocyte differentiation. The protein is characterized by a basic leucine zipper (bZIP) domain that facilitates DNA binding and dimerization. This domain is crucial for the protein's function, as it is responsible for DNA-protein interactions (Serwas2018CEBPE-Mutant). The bZIP domain includes a basic region for DNA binding and a leucine zipper for dimerization, which is a common feature in the C/EBP family (Serwas2018CEBPE-Mutant).

The primary structure of C/EBPε includes a conserved bZIP region, which is essential for its role as a transcription factor. The secondary structure typically involves alpha-helices, which are common in proteins with bZIP domains. The tertiary structure is stabilized by the bZIP domain, allowing the protein to form homodimers or heterodimers, which is part of its quaternary structure (Serwas2018CEBPE-Mutant).

Post-translational modifications of C/EBPε may include sumoylation, which enhances its activity and affects its cellular and nuclear localization (Serwas2018CEBPE-Mutant). The protein can also undergo phosphorylation, a common modification in transcription factors, although specific details on phosphorylation sites are not provided in the context. Splice variants of CEBPE can result in different isoforms, which may have distinct functions, although specific isoforms are not detailed in the provided context.

## Function
The CEBPE gene encodes the transcription factor CCAAT/enhancer-binding protein epsilon (C/EBPε), which is crucial for the differentiation and function of granulocytes, particularly neutrophils and eosinophils. In healthy human cells, C/EBPε is involved in the transcriptional regulation of genes necessary for the proper formation and function of neutrophil granules. It is active in the nucleus, where it regulates the transcription of components of the secondary and tertiary granules in neutrophils and eosinophils, and influences nuclear segmentation (Serwas2018CEBPE-Mutant).

C/EBPε expression peaks at the myelocyte and metamyelocyte stages of neutrophil development, indicating its role in early neutrophil differentiation. It is almost absent in mature cells, suggesting its function is primarily during the early stages of granulocytic differentiation (Serwas2018CEBPE-Mutant). C/EBPε also plays a role in inhibiting MYC-dependent G1/S phase progression and is involved in the regulation of genes during terminal granulocytic differentiation, promoting cell cycle exit and the specification of cell identity (TheilgaardMönch2022P1413:). This transcription factor is essential for the immune response, as it ensures the proper development and function of granulocytes, which are critical for fighting infections (Yamanaka1997Impaired).

## Clinical Significance
Mutations in the CEBPE gene are associated with several hematological disorders. Specific granule deficiency (SGD) is a rare condition linked to mutations in CEBPE, characterized by abnormal neutrophils with reduced granules and atypical bilobed nuclei. The p.Val218Ala mutation in CEBPE leads to defects in granule distribution and protein content, affecting neutrophil function and surface marker expression (Serwas2018CEBPE-Mutant). This mutation prevents the nuclear localization of the C/EBPε protein, disrupting the transcription of granule components and altering the proteome of neutrophils (Serwas2018CEBPE-Mutant).

A gain-of-function mutation, Arg219His, in CEBPE is associated with a noncanonical autoinflammatory condition termed inflammasomopathy. This mutation results in increased chromatin binding of C/EBPε, leading to dysregulated transcription of genes involved in inflammatory responses and inflammasome activation. Patients with this mutation exhibit symptoms such as recurrent abdominal pain, aseptic fever, and systemic inflammation (Göös2019Gainoffunction).

Additionally, certain single nucleotide polymorphisms (SNPs) in CEBPE, such as rs4982731, have been associated with an increased risk of acute lymphoblastic leukemia (ALL) in specific populations, particularly in Hispanic children (Hsu2015Association).

## Interactions
CEBPE (CCAAT enhancer binding protein epsilon) is involved in various protein-protein and protein-DNA interactions that are crucial for its function in myeloid differentiation and immune response regulation. The Arg219His mutation in CEBPE affects its protein-protein interactions, notably reducing its interaction with the SWI/SNF chromatin remodeling complex subunit SMARCC2, which is a regulator of myeloid differentiation. This mutation also downregulates interactions with other SWI/SNF-related proteins such as SNF5, SMRD1, SMRD2, and SMCE1 (Göös2019Gainoffunction).

CEBPE interacts with E2F transcription factors, particularly E2F1, to repress E2F-mediated gene expression during granulocytic differentiation. This interaction is crucial for the downregulation of G2/M phase genes and the promotion of cell cycle exit (TheilgaardMönch2022P1413:). CEBPE also binds to enhancers of genes upregulated during late granulocytic differentiation, indicating its role in specifying granulocytic cell identity (TheilgaardMönch2022P1413:).

In the context of specific granule deficiency (SGD), the Val218Ala mutation in CEBPE prevents the nuclear localization of the protein, affecting its ability to bind DNA and regulate the transcription of granule proteins (Serwas2018CEBPE-Mutant).


## References


[1. (Serwas2018CEBPE-Mutant) Nina K. Serwas, Jakob Huemer, Régis Dieckmann, Ester Mejstrikova, Wojciech Garncarz, Jiri Litzman, Birgit Hoeger, Ondrej Zapletal, Ales Janda, Keiryn L. Bennett, Renate Kain, Dontscho Kerjaschky, and Kaan Boztug. Cebpe-mutant specific granule deficiency correlates with aberrant granule organization and substantial proteome alterations in neutrophils. Frontiers in Immunology, March 2018. URL: http://dx.doi.org/10.3389/fimmu.2018.00588, doi:10.3389/fimmu.2018.00588. This article has 33 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2018.00588)

[2. (Yamanaka1997Impaired) Ryuya Yamanaka, Carrolee Barlow, Julie Lekstrom-Himes, Lucio H. Castilla, Pu P. Liu, Michael Eckhaus, Thomas Decker, Anthony Wynshaw-Boris, and Kleanthis G. Xanthopoulos. Impaired granulopoiesis, myelodysplasia, and early lethality in ccaat/enhancer binding protein ɛ-deficient mice. Proceedings of the National Academy of Sciences, 94(24):13187–13192, November 1997. URL: http://dx.doi.org/10.1073/pnas.94.24.13187, doi:10.1073/pnas.94.24.13187. This article has 310 citations.](https://doi.org/10.1073/pnas.94.24.13187)

[3. (TheilgaardMönch2022P1413:) K. Theilgaard-Mönch, S. Pundhir, K. Kristian Reckzeh, J. Su, M. Tapia, B. Furtwängler, J. Jendholm, and J. Schou Jakobsen. P1413: transcription factor-driven coordination of cell cycle exit and specification of cell identity in vivo during granulocytic differentiation - in memoriam prof. niels borregaard. HemaSphere, 6:1297–1298, June 2022. URL: http://dx.doi.org/10.1097/01.hs9.0000848512.71252.a1, doi:10.1097/01.hs9.0000848512.71252.a1. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/01.hs9.0000848512.71252.a1)

[4. (Göös2019Gainoffunction) Helka Göös, Christopher L. Fogarty, Biswajyoti Sahu, Vincent Plagnol, Kristiina Rajamäki, Katariina Nurmi, Xiaonan Liu, Elisabet Einarsdottir, Annukka Jouppila, Tom Pettersson, Helena Vihinen, Kaarel Krjutskov, Päivi Saavalainen, Asko Järvinen, Mari Muurinen, Dario Greco, Giovanni Scala, James Curtis, Dan Nordström, Robert Flaumenhaft, Outi Vaarala, Panu E. Kovanen, Salla Keskitalo, Annamari Ranki, Juha Kere, Markku Lehto, Luigi D. Notarangelo, Sergey Nejentsev, Kari K. Eklund, Markku Varjosalo, Jussi Taipale, and Mikko R.J. Seppänen. Gain-of-function cebpe mutation causes noncanonical autoinflammatory inflammasomopathy. Journal of Allergy and Clinical Immunology, 144(5):1364–1376, November 2019. URL: http://dx.doi.org/10.1016/j.jaci.2019.06.003, doi:10.1016/j.jaci.2019.06.003. This article has 36 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.jaci.2019.06.003)

[5. (Hsu2015Association) Ling-I. Hsu, Anand P. Chokkalingam, Farren B. S. Briggs, Kyle Walsh, Vonda Crouse, Cecilia Fu, Catherine Metayer, Joseph L. Wiemels, Lisa F. Barcellos, and Patricia A. Buffler. Association of genetic variation in ikzf1, arid5b, and cebpe and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in hispanic children. Cancer Causes &amp; Control, 26(4):609–619, March 2015. URL: http://dx.doi.org/10.1007/s10552-015-0550-3, doi:10.1007/s10552-015-0550-3. This article has 20 citations.](https://doi.org/10.1007/s10552-015-0550-3)